NFL Biosciences (XPAR:ALNFL) Total Liabilities : €3.62 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Total Liabilities?

NFL Biosciences's Total Liabilities for the quarter that ended in Dec. 2023 was €3.62 Mil.

NFL Biosciences's quarterly Total Liabilities increased from Dec. 2022 (€1.55 Mil) to Jun. 2023 (€3.67 Mil) but then declined from Jun. 2023 (€3.67 Mil) to Dec. 2023 (€3.62 Mil).

NFL Biosciences's annual Total Liabilities increased from Dec. 2021 (€0.40 Mil) to Dec. 2022 (€1.55 Mil) and increased from Dec. 2022 (€1.55 Mil) to Dec. 2023 (€3.62 Mil).

NFL Biosciences Total Liabilities Historical Data

The historical data trend for NFL Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Total Liabilities Chart

NFL Biosciences Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

0.06

0.43

0.40

1.55

3.62

NFL Biosciences Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial			0.40	0.83	1.55	3.67	3.62

NFL Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

NFL Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.621	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.62

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3.971	-	0.35
	=	3.62

NFL Biosciences's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.621	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.62

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	3.971	-	0.35
	=	3.62

NFL Biosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

NFL Biosciences (XPAR:ALNFL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

82F:Germany

Address

199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170

Website

https://www.nflbiosciences.com/

NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines